These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30287796)

  • 1. Probing the Occurrence of Soluble Oligomers through Amyloid Aggregation Scaling Laws.
    Silva A; Sárkány Z; Fraga JS; Taboada P; Macedo-Ribeiro S; Martins PM
    Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30287796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of Amyloid-Like and Oligomeric Species from Protein Aggregation Kinetics.
    Silva A; Almeida B; Fraga JS; Taboada P; Martins PM; Macedo-Ribeiro S
    Angew Chem Int Ed Engl; 2017 Nov; 56(45):14042-14045. PubMed ID: 28906069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of oligomers of heterogeneous size as precursors of amyloid fibril nucleation of an SH3 domain: an experimental kinetics study.
    Ruzafa D; Morel B; Varela L; Azuaga AI; Conejero-Lara F
    PLoS One; 2012; 7(11):e49690. PubMed ID: 23209591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effect of non-ionic detergent Triton X-100 on insulin amyloid formation.
    Siposova K; Sedlak E; Kozar T; Nemergut M; Musatov A
    Colloids Surf B Biointerfaces; 2019 Jan; 173():709-718. PubMed ID: 30384267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic diversity of amyloid oligomers.
    Dear AJ; Michaels TCT; Meisl G; Klenerman D; Wu S; Perrett S; Linse S; Dobson CM; Knowles TPJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12087-12094. PubMed ID: 32414930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the enhanced inhibitory, disaggregating and cytoprotective potential of promethazine towards amyloid fibrillation.
    Nusrat S; Zaman M; Masroor A; Siddqi MK; Zaidi N; Neelofar K; Abdelhameed AS; Khan RH
    Int J Biol Macromol; 2018 Jan; 106():851-863. PubMed ID: 28823512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insoluble Off-Pathway Aggregates as Crowding Agents during Amyloid Fibril Formation.
    Crespo R; Villar-Alvarez E; Taboada P; Rocha FA; Damas AM; Martins PM
    J Phys Chem B; 2017 Mar; 121(10):2288-2298. PubMed ID: 28221799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Amyloid Aggregation Kinetics: A Case Study with Sup35NM.
    Sharma A; McDonald MA; Rose HB; Chernoff YO; Behrens SH; Bommarius AS
    J Phys Chem B; 2021 May; 125(19):4955-4963. PubMed ID: 33961433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single Molecule Characterization of Amyloid Oligomers.
    Yang J; Perrett S; Wu S
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomeric states along the folding pathways of β2-microglobulin: kinetics, thermodynamics, and structure.
    Rennella E; Cutuil T; Schanda P; Ayala I; Gabel F; Forge V; Corazza A; Esposito G; Brutscher B
    J Mol Biol; 2013 Aug; 425(15):2722-36. PubMed ID: 23648836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the stability of amyloidogenic precursors by anion binding strongly influences the rate of amyloid nucleation.
    Ruzafa D; Conejero-Lara F; Morel B
    Phys Chem Chem Phys; 2013 Oct; 15(37):15508-17. PubMed ID: 23942905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model.
    Faria TQ; Almeida ZL; Cruz PF; Jesus CS; Castanheira P; Brito RM
    Phys Chem Chem Phys; 2015 Mar; 17(11):7255-63. PubMed ID: 25694367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A covalent homodimer probing early oligomers along amyloid aggregation.
    Halabelian L; Relini A; Barbiroli A; Penco A; Bolognesi M; Ricagno S
    Sci Rep; 2015 Sep; 5():14651. PubMed ID: 26420657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent insulin oligomer reaction pathway prior to fibril formation: cooling and seeding.
    Sorci M; Grassucci RA; Hahn I; Frank J; Belfort G
    Proteins; 2009 Oct; 77(1):62-73. PubMed ID: 19408310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-inhibition of insulin amyloid-like aggregation.
    Ziaunys M; Sneideris T; Smirnovas V
    Phys Chem Chem Phys; 2018 Nov; 20(43):27638-27645. PubMed ID: 30374505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy.
    Lindgren M; Sörgjerd K; Hammarström P
    Biophys J; 2005 Jun; 88(6):4200-12. PubMed ID: 15764666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and Lispro Insulin: What is Common and Different in their Behavior?
    Selivanova OM; Suvorina MY; Surin AK; Dovidchenko NV; Galzitskaya OV
    Curr Protein Pept Sci; 2017; 18(1):57-64. PubMed ID: 27226198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin adsorption onto zinc oxide nanoparticle mediates conformational rearrangement into amyloid-prone structure with enhanced cytotoxic propensity.
    Asthana S; Hazarika Z; Nayak PS; Roy J; Jha AN; Mallick B; Jha S
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):153-166. PubMed ID: 30315849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mysterious oligomerization of the amyloidogenic proteins.
    Uversky VN
    FEBS J; 2010 Jul; 277(14):2940-53. PubMed ID: 20546306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of small oligomers on the amyloidogenic aggregation free-energy landscape.
    He X; Giurleo JT; Talaga DS
    J Mol Biol; 2010 Jan; 395(1):134-54. PubMed ID: 19837085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.